eMAR Systems in 2026:
100 Statistics, Data & Trends
Electronic Medication Administration Records — Market, Safety, Adoption & Technology
Market Size & Growth
STATS 1–14eMAR long-term care software sub-market value in 2023 (Grand View Research)
Expected LTC eMAR sub-market size by 2030, at 8.5% CAGR (Grand View Research)
LTC eMAR software segment compound annual growth rate 2023–2030 (Grand View Research)
Global long-term care software market (incl. eMAR) value in 2024 (Data Bridge Market Research)
Global LTC software market projected size by 2032 at 10.8% CAGR (Data Bridge Market Research)
North America's share of global LTC software market revenue in 2024 (Market.us)
Global EHR market size in 2025 — the broader ecosystem supporting eMAR adoption (Grand View Research)
EHR market CAGR 2026–2033, reaching 3.1B — anchoring eMAR demand growth (Grand View Research)
Share of EHR revenue from web/cloud-based solutions in 2025, accelerating eMAR SaaS adoption (Grand View Research)
U.S. Healthcare IT software market size in 2024, growing at 15.46% CAGR to 89B by 2030 (Research & Markets)
CAGR of cloud-based LTC software deployments 2025–2030, making SaaS eMAR the dominant model (Mordor Intelligence)
Europe eMAR software market size in 2024 — the second-largest regional market globally (Growth Market Reports)
Medication Errors & Patient Safety
STATS 15–35WHO estimates 1 in 30 patients experiences medication-related harm — a global patient safety emergency (WHO, 2024)
Half of all preventable harm in medical care is medication-related, says WHO — eMAR directly addresses this (WHO, 2022)
Nearly 1 in 4 preventable medication harms results in severe or life-threatening consequences (WHO Systematic Review, 2024)
Between 7,000 and 9,000 Americans die annually from medication errors, per FDA and AHRQ data (AHRQ)
Adverse drug events (ADEs) cause ~1.5 million emergency department visits in the U.S. annually (Healthy People 2030)
ADEs result in .5 billion in excess U.S. medical costs annually (Healthy People 2030, HHS)
Reported incidence of medication errors is approximately 6.5 per 100 acute hospital admissions (StatPearls, 2024)
Medication error rate during patient administration ranges from 8% to 25% in hospital and LTC settings (Renew Bariatrics, 2024)
The FDA receives over 100,000 medication error reports annually — highlighting the scale that eMAR must address (Renew Bariatrics, 2024)
Over 7 million U.S. patients annually experience some adverse effect from medication errors (Renew Bariatrics, 2024)
About 530,000 injury incidents in outpatient clinics annually result from medication errors (Renew Bariatrics, 2024)
In a UK study, 69.5% of care home residents were exposed to one or more medication errors — reinforcing eMAR's necessity (NCBI)
BCMA-eMAR Clinical Impact
STATS 36–52Sources: NEJM (2010), TechTarget/AHRQ, NCBI PMC8678992 (2021)
BCMA-eMAR reduces non-timing medication errors by 41.4% — a landmark finding published in NEJM (NEJM, 2010)
Potential adverse drug events drop by 51% when BCMA is paired with eMAR, per landmark research (TechTarget/AHRQ)
Emergency departments using BCMA-eMAR see error prevention rates approaching 80% (TechTarget/AHRQ)
Medical ICU medication errors decreased by 56% after robust BCMA deployment (DeYoung, 2009 / NCBI PMC11958195)
Central automated dispensing combined with BCMA-eMAR can reduce medication errors by up to 94% (NCBI PMC8678992)
Avoiding a single ADE saves between ,000 and ,000 in direct healthcare costs (TechTarget/AHRQ)
Patient BCMA scanning compliance rates range from 4.6% to 89% across wards in real-world hospital settings (BMJ Health Informatics, 2025)
Medication accuracy rate improved significantly post BCMA-eMAR implementation, reaching 96% in one hospital study (ResearchGate, 2021)
eMAR Plus cut medication administration documentation time by 50% at Antrim Care Home (eMAR Plus, 2025)
Studies show BCMA alone achieves 30–60% relative reductions in medication administration error rates (NCBI PMC8678992)
A 100-resident assisted living community administers approximately 1,400 medications daily — requiring robust eMAR oversight (August Health, 2025)
Some senior living residents have 60+ concurrent medications on their eMAR — a polypharmacy challenge driving advanced analytics (August Health, 2025)
Vendor Landscape & Market Share
STATS 53–66| Vendor | Segment | Market Share / Key Stat | Year |
|---|---|---|---|
| Epic Systems | Acute Care EHR/eMAR | 43.7% acute care hospital EHR market share | 2025 |
| Epic Systems | Hospital Beds | 54.9% of U.S. acute care hospital beds | 2025 |
| Oracle Health | Acute Care EHR/eMAR | 21.9% acute care hospital market share | 2025 |
| MEDITECH | Acute Care EHR/eMAR | 14.7% acute care hospital market share | 2025 |
| PointClickCare | Long-Term Care eMAR | #1 LTC eMAR/EHR market share (KLAS) | 2024 |
| MatrixCare | Long-Term Care eMAR | #2 LTC eMAR/EHR market share (KLAS) | 2024 |
| Epic – Net Gain | 2024 Hospital Contracts | Won ~70% of all new hospital EHR contracts (KLAS) | 2024 |
Epic controls 54.9% of U.S. hospital beds, meaning over half of all inpatient medication administrations pass through Epic's eMAR (KLAS Research, 2025)
Epic added 77 net acute care hospitals in 2025, growing market share for the 5th consecutive year (KLAS Research, 2026)
Oracle Health saw a net loss of 56 hospitals in 2025 as healthcare systems increasingly consolidate onto Epic-integrated eMAR workflows (KLAS Research, 2026)
Over 85% of U.S. nursing homes have implemented digital documentation systems including eMAR, driven by AHCA programs (Market Data Forecast, 2025)
Adoption, Demographics & Care Settings
STATS 67–82The U.S. has over 1.6 million certified nursing home beds in 2024–25, all requiring eMAR-compliant medication management (CMS, via Precedence Research)
Nearly 15,000 Medicare- and Medicaid-certified nursing homes operate in the U.S., representing a massive eMAR deployment opportunity (The Senior List, 2026)
Over 1.2 million people reside in U.S. nursing homes — each requiring daily medication administration records via eMAR (The Senior List, 2026)
About 70% of U.S. adults will need some form of long-term care — driving the long-term structural demand for eMAR systems (SingleCare, 2026)
Australia reported 220,000+ residential aged care places in 2024–25, with expanding eMAR rollout requirements (AIHW, via Precedence Research)
Home care agencies held the largest LTC software segment share at 31.1% in 2024, with eMAR functionality increasingly deployed via mobile devices (Market.us)
40% of U.S. adults have more than one chronic condition, compounding medication complexity and the critical need for eMAR systems (HHS)
Approximately 96% of U.S. hospitals have adopted certified EHR technology — the infrastructure backbone for integrated eMAR systems (ONC Health IT)
The U.S. LTC software market reached .41 billion in 2025 and is projected to reach .11 billion by 2033 at 6.92% CAGR (Grand View Research)
The global EHR/EMR market is estimated at 1.8 billion in 2026, with eMAR functionality integral to nearly all platforms (Straits Research)
Ambulatory care centers are the fastest-growing EHR/eMAR end-user segment at 8% CAGR through 2034, expanding eMAR beyond hospitals (Straits Research)
Asia-Pacific is the fastest-growing EHR/eMAR regional market at 6.2% CAGR — driven by India, China, and Southeast Asia's digital health push (Straits Research)
Technology Trends & Innovation
STATS 83–100AI methods are now applied to optimize BCMA-eMAR medication alerts, reducing alert fatigue — a top barrier to clinical adoption (JAMIA/NCBI, 2024)
45.1% of LTC software revenue in 2025 comes from web-based/cloud deployments — eMAR SaaS is the dominant delivery model (Mordor Intelligence)
In 2025 and beyond, mobile-first eMAR platforms with voice, AI, and real-time pharmacy integration are now the baseline expectation, not a premium feature (ECP, 2024)
The LTC sector lost ~229,000 caregivers since Feb 2020 — driving urgent adoption of eMAR systems to automate and sustain medication management with fewer staff (SingleCare, 2026)
58% of nursing homes expect to reduce staff due to lower Medicaid reimbursement — making eMAR efficiency gains financially critical (AHCA Survey, 2025)
In high-income countries, approximately 15% of total health spending goes to managing consequences of patient harm — eMAR-driven prevention directly lowers this burden (WHO, 2024)